Bio-Rad Laboratories, Inc. Class A Common Stock vs Verizon Communications Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Verizon Communications Inc trades at $47.15 (market cap $196.40B). The key difference: Verizon Communications Inc is far larger — about 20.8× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Verizon Communications Inc pays a 5.99% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | VZ | |
|---|---|---|
Market Cap | $9.43B | $196.40B |
Sector | Health | Media |
52-Week High | $356.25 | $51.38 |
52-Week Low | $241.71 | $38.40 |
Enterprise Value | $9.18B | $383.10B |
Volume | — | 22,584,735 |
Dividend Yield | — | 5.99% |
Trailing returns across standard periods
Latest headlines on both assets
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →